← Back to Search

Treatment Group 1: BMS-986166 for Healthy Subjects

Phase 1
Waitlist Available
Research Sponsored by Bristol-Myers Squibb
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Healthy male participants as determined by no clinically significant deviation from normal in medical history, physical examination, 12-lead ECGs, or clinical laboratory determinations
Body mass index between 18.0 to 33.0 kg/m2 (inclusive)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 124 days
Awards & highlights

Study Summary

The purpose of this study is to assess the drug levels of BMS-986166 in healthy male participants.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You have a body mass index between 18.0 and 33.0 kg/m2 (inclusive).

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 124 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 124 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percent of TRA recovered in feces (%FR)
Percent of TRA recovered in urine (%UR)
Percent of TRA recovered in urine and feces combined (%TOTAL)
+3 more
Secondary outcome measures
Area under the concentration-time curve from time zero to time of the last quantifiable concentration [AUC(0-T)]
Maximum observed concentration (Cmax)
Number of participants with adverse events (AEs)
+6 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Treatment Group 1: BMS-986166Experimental Treatment2 Interventions
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
BMS-986166
2022
Completed Phase 2
~370
Bisacodyl
FDA approved

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Bristol-Myers SquibbLead Sponsor
2,629 Previous Clinical Trials
4,126,529 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
Missouri
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
~3 spots leftby Mar 2025